Holen Sie sich die Stockscreener-App
17.13
0.52%
-0.09
Schlusskurs vom Vortag:
$17.22
Offen:
$17.43
24-Stunden-Volumen:
546.74K
Relative Volume:
0.59
Marktkapitalisierung:
$881.04M
Einnahmen:
$312.78M
Nettoeinkommen (Verlust:
$-143.56M
KGV:
-6.368
EPS:
-2.69
Netto-Cashflow:
$1.22M
1W Leistung:
-10.50%
1M Leistung:
-11.01%
6M Leistung:
-15.53%
1J Leistung:
-28.63%
1-Tages-Spanne:
$16.94
$17.57
1-Wochen-Bereich:
$16.94
$20.13
52-Wochen-Spanne:
$10.96
$25.95
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Vergleichen Sie CDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
17.13 | 885.67M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
618.86 | 227.87B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
238.37 | 165.99B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
713.35 | 56.89B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
148.52 | 41.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
242.41 | 41.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
Aug Opening: Can CareDx Inc stock continue upward trendJuly 2025 Momentum & Fast Exit/Entry Strategy Plans - ulpravda.ru
Can CareDx Inc stock hit record highs again2025 Earnings Surprises & Daily Stock Momentum Reports - ulpravda.ru
Dow Update: Will CareDx Inc (1K9) stock gain from lower interest ratesJuly 2025 Macro Moves & AI Enhanced Trading Alerts - ulpravda.ru
Why retail investors pile into CareDx Inc stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - ulpravda.ru
Why CareDx Inc stock is in analyst buy zoneMarket Activity Summary & Verified Momentum Stock Ideas - ulpravda.ru
Can CareDx Inc stock continue upward trendShare Buyback & Entry Point Strategy Guides - ulpravda.ru
CareDx and 10x Genomics partner on transplant rejection research By Investing.com - Investing.com Nigeria
CareDx (CDNA) director Michael Goldberg receives 1,492-share equity grant - Stock Titan
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response - BioSpace
Assessing CareDx (CDNA) Valuation After ImmuneScape Multiomics Collaboration With 10x Genomics - Sahm
CareDx, 10x Genomics Establish Multiomics Research Initiative - Contract Pharma
CareDx, 10x Genomics Launch Platform to Study Transplant Rejection and Drug Response - MarketScreener
CareDx, Inc. and 10x Genomics to Launch ImmuneScapeA Multiomics Research Platform to Decode Transplant Rejection and Drug Response - MarketScreener
CareDx and 10x Genomics partner on transplant rejection research - Investing.com India
CareDx wins preliminary court approval for derivative settlement - MSN
CareDx (NASDAQ:CDNA) Shares Gap DownHere's Why - MarketBeat
Craig-Hallum downgrades CareDx stock rating to Hold from Buy By Investing.com - Investing.com Canada
Craig-Hallum downgrades CareDx stock rating to Hold from Buy - Investing.com
What drives CareDx Inc 1K9 stock priceFinancial Sector Performance & Low Cost Investment Portfolio - earlytimes.in
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eagle-Tribune
Should CareDx’s Governance Settlement and ESOP Shift Require Action From CareDx (CDNA) Investors? - simplywall.st
CareDx price target raised to $18 from $14 at Wells Fargo - MSN
CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade) (CDNA) - Seeking Alpha
CareDx, Inc. (NASDAQ:CDNA) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
CareDx (CDNA): Reassessing Valuation After Governance Reform Settlement and Legal Resolution Proposal - Sahm
CareDx (NASDAQ:CDNA) Rating Increased to Buy at Wall Street Zen - MarketBeat
Will CareDx Inc stock benefit from commodity pricesShare Buyback & Capital Efficient Trade Techniques - Улправда
Short Covering: Why CareDx Inc stock is popular among millennialsJuly 2025 PostEarnings & Fast Gain Swing Trade Alerts - Улправда
Is CareDx Inc stock a bargain at current levels2025 Pullback Review & Entry and Exit Point Strategies - Улправда
Wells Fargo maintains CareDx (CDNA) equal-weight recommendation - MSN
Will CareDx Inc stock outperform Dow Jones index2025 Market Trends & High Win Rate Trade Alerts - Улправда
Why CareDx Inc stock is popular among millennialsMarket Performance Recap & Weekly High Conviction Trade Ideas - Улправда
CareDx (NASDAQ: CDNA) secures preliminary approval for shareholder derivative settlement - Stock Titan
CareDx provides notice of proposed derivative settlement - marketscreener.com
CareDx Provides Notice Of Proposed Derivative Settlement - TradingView — Track All Markets
CareDx Wins Preliminary Court Approval for Derivative Settlement - TipRanks
CareDx, Inc. Reaches Preliminary Settlement in Shareholder Derivative Litigation - TradingView — Track All Markets
CareDx Provides Notice of Proposed Derivative Settlement - Yahoo Finance
Squarepoint Ops LLC Has $2.77 Million Stock Holdings in CareDx, Inc. $CDNA - MarketBeat
Transplantation Market to Reach US$ 31.92 Billion by 2032 at 8.6% - openPR.com
CareDx (NASDAQ: CDNA) adopts majority voting and director resignation rules - Stock Titan
CDNA: Wells Fargo Raises Price Target to $18, Maintains Equal-We - GuruFocus
Trading the Move, Not the Narrative: (CDNA) Edition - Stock Traders Daily
CareDx (CDNA): Rethinking Valuation After a Sharp Short-Term Share Price Rebound - Yahoo Finance
Nikko Asset Management Americas Inc. Reduces Position in CareDx, Inc. $CDNA - MarketBeat
CareDx Shares Navigate Conflicting Market Signals - AD HOC NEWS
There's No Escaping CareDx, Inc's (NASDAQ:CDNA) Muted Revenues Despite A 26% Share Price Rise - 富途牛牛
CareDx, Inc. $CDNA Shares Sold by Bellevue Group AG - MarketBeat
CareDx (NASDAQ:CDNA) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
CareDx Reports Strong Q3 2025 Financial Results - MSN
Stocks Showing Improved Relative Strength: CareDx - MSN
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):